Today: 9 June 2026
RBC stock: Eurasia Group pact and Canada jobs put two dates on investors’ radar
10 January 2026
2 mins read

RBC stock: Eurasia Group pact and Canada jobs put two dates on investors’ radar

Toronto, Jan 10, 2026, 15:29 EST — Market closed.

  • Starting in 2026, Royal Bank of Canada will launch a three-year partnership with Eurasia Group
  • RBC shares closed with a split move Friday: down 0.2% on the NYSE, but up 0.2% in Toronto
  • Up next: Bank of Canada rate decision on Jan. 28 and RBC earnings on Feb. 26

Royal Bank of Canada announced plans to launch a three-year strategic partnership with political risk consultancy Eurasia Group starting in 2026. On Friday, RBC’s U.S. shares slipped 0.2% to close at $169.19, while its Toronto-listed stock edged up 0.2% to C$235.52.

The deal comes as officials and companies gear up for the initial six-year joint review of the USMCA, the North American trade agreement, set for July 1, 2026. Trade policy is creeping back into market pricing, and cross-border lenders are once again fielding questions about the fallout if tensions escalate.

Canada’s December labour report dropped on Friday, showing job growth tapering off as the economy added a net 8,200 positions. The unemployment rate ticked up to 6.8%. Wage growth slowed compared to November, a key figure for gauging inflation pressures and interest rate moves.

Eurasia Group and RBC announced plans to co-host several events, highlighted by the 2026 US-Canada Summit set for June 10–11 in Toronto. Ian Bremmer of Eurasia Group described the US-Canada relationship as “deeply geopolitical,” while RBC CEO Dave McKay emphasized that “trusted partnerships matter more than ever.” GlobeNewswire

RBC’s New York shares fluctuated between roughly $168.80 and $170.78 across the last two sessions. The $170 mark has acted as a near-term threshold for traders, following a rally that left little wiggle room for unexpected moves.

Investors in Canada’s resource-heavy equity market are showing caution, Reuters reported Friday, as focus shifts to upcoming labour data and a U.S. Supreme Court decision related to tariffs. The benchmark TSX has hovered close to a record high reached earlier this week.

Importers in the U.S. are gearing up for a possible battle over up to $150 billion in refunds if the Supreme Court rejects President Donald Trump’s emergency tariffs, Reuters reported. While not a banking story by itself, the case directly affects trade, growth, and credit prospects in Canada’s export-driven sectors.

That said, the stock’s fate hinges more on economic swings than on what’s said at conferences. A downturn or tariff disruption could drive loan losses up. Canada’s largest bank, in its latest quarter, carved out C$1 billion for potential loan write-offs, Reuters reported last December.

The next key date is the Bank of Canada’s rate decision on Jan. 28. Banks closely follow rate forecasts since borrowing costs influence mortgage demand and net interest margins — the gap between what lenders earn and pay.

Statistics Canada plans to release annual revisions to seasonally adjusted labour force figures on Jan. 26, with the next monthly labour report set for Feb. 6. Even minor tweaks in these updates can quickly alter the rate story.

RBC’s next key event is the first-quarter earnings report, scheduled for Feb. 26 at 8:30 a.m. ET, per its investor relations calendar. Investors will focus on credit-loss provisions and shifts in loan growth forecasts amid growing chatter on trade and interest rates heading into 2026.

Stock Market Today

  • Eloxx Pharmaceuticals Prices $66 Million Offering, Uplists to Nasdaq
    June 8, 2026, 10:12 PM EDT. Eloxx Pharmaceuticals, a clinical-stage biopharma firm, priced a $66 million public offering including common stock and pre-funded warrants. The offering includes 2.975 million shares at $11 each and warrants for 3.025 million shares priced at $10.99 each. Proceeds will support development of Eloxx's novel small molecule therapies targeting genetic diseases caused by nonsense mutations. Eloxx's shares will begin trading on Nasdaq Capital Market on June 9, 2026, under the ticker ELOX. The deal is led by Leerink Partners and Guggenheim Securities with LifeSci Capital as passive bookrunner. This uplisting to Nasdaq marks a key step in expanding Eloxx's market presence and funding pipeline advancement.

Latest articles

Chip Rally Breaks as Nasdaq Faces Tight Labor Market

Nasdaq rises after hours as chips recover

9 June 2026
Nasdaq jumped 0.86% as chip stocks rebounded, with Intel soaring 11.2% on news Google ordered over 3 million AI chips for 2028, while Apple slid 1.9% after unveiling new AI features. Investors await Wednesday’s May CPI inflation report, which could spark volatility in tech and growth stocks.
Broadcom Stock Rebounds, AI Remains an Open Question for Wall Street

Broadcom Stock Rebounds, AI Remains an Open Question for Wall Street

9 June 2026
Broadcom shares jumped 2.8% to $396.60 as chip stocks rebounded after last week’s $1 trillion sector wipeout, but investors remain cautious after Broadcom’s Q2 revenue missed expectations and the company declined to raise its 2027 AI revenue forecast, fueling concerns that rapid AI growth may not meet Wall Street’s high demands.
BitMine Stock Gains as Ether Holdings Approach 5% Target

BitMine Stock Gains as Ether Holdings Approach 5% Target

9 June 2026
BitMine Immersion Technologies shares jumped 6% after revealing ether holdings climbed to 5.54 million tokens, now 4.59% of Ethereum’s supply, with $9.6 billion in crypto, cash and stakes. The company priced a $273.8 million preferred stock offering, with proceeds possibly funding more ETH purchases and staking. BitMine projects $230 million in annualized staking revenues but warns of risks if ETH or financing falters.
Mingteng Stock Jumps 81% After Halting $100M Share Sale Plan

Mingteng Stock Jumps 81% After Halting $100M Share Sale Plan

9 June 2026
Mingteng International shares soared 81.3% to $1.94 after the company ended its at-the-market stock sale plan, having raised about $20.6 million in gross proceeds; trading volume hit 24.2 million, dwarfing its $12 million market value, as the move outpaced gains in other U.S.-listed China auto stocks.
Why Kweichow Moutai Co., Ltd. Class A stock (600519) is in focus: iMoutai restock and a fresh target cut
Previous Story

Why Kweichow Moutai Co., Ltd. Class A stock (600519) is in focus: iMoutai restock and a fresh target cut

BigBear.ai stock (BBAI) eyes Monday open after Kraft Group, Patriots tie-up; share vote looms
Next Story

BigBear.ai stock (BBAI) eyes Monday open after Kraft Group, Patriots tie-up; share vote looms

Go toTop